Drug watch.
- Published in:
- 2006
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2006 AND VI 41
Results: 325
1
2
Drug and formulary trends.
- Published in:
- 2006
- Publication type:
- Journal Article
3
Update: pioglitazone patent term extension.
- Published in:
- 2006
- Publication type:
- Journal Article
4
FDA actions in brief.
- Published in:
- 2006
- Publication type:
- Journal Article
5
Clinical news updates from the 2006 AHA Scientific Sessions.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
6
Focus on... Aliskiren: a novel oral renin inhibitor for the treatment of hypertension.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
7
Effects of evidence-based formulary restrictions at a Veterans Affairs medical center.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
8
Drug Watch.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 672
- Publication type:
- Article
9
Update: pioglitazone patent term extension.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 671
- Publication type:
- Article
10
Drug and Formulary Trends.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 671
- Publication type:
- Article
11
Medco reaches settlement with Department of Justice; legal paper seeks change in FDA warning letter process.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 669
- Publication type:
- Article
12
Effects of evidence-based formulary restrictions at a Veterans Affairs medical center.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 657
- By:
- Publication type:
- Article
13
Correction.
- Published in:
- 2006
- Publication type:
- Correction Notice
14
Study confirms high prevalence of Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 656
- Publication type:
- Article
15
Clinical news updates from the 2006 AHA Scientific Sessions.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 643
- By:
- Publication type:
- Article
16
Alskiren: A novel oral renin inhibitor for the treatment of hypertension.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 631
- By:
- Publication type:
- Article
17
NSAID use in first trimester may increase risk of congenital anomalies.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 624
- Publication type:
- Article
18
ADEs responsible for more than 700,000 visits to US emergency departments in 2004 and 2005.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 624
- Publication type:
- Article
19
FDA actions in brief.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 622
- Publication type:
- Article
20
FDA Drug Approvals.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 618
- Publication type:
- Article
21
Pipeline preview.
- Published in:
- Formulary, 2006, v. 41, n. 12, p. 618
- Publication type:
- Article
22
Clinical insights in immunoglobulin for intravenous (IGIV) therapy.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
23
Drug watch.
- Published in:
- 2006
- Publication type:
- Journal Article
24
Drug and formulary trends.
- Published in:
- 2006
- Publication type:
- Journal Article
25
Rimonabant: A novel CB1 receptor antagonist for the treatment of obesity.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
26
Focus on 2006: a year of novel pharmacologic agents in review.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
27
FDA drug approvals. FDA actions in brief.
- Published in:
- 2006
- Publication type:
- Journal Article
28
Drug Watch.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 612
- Publication type:
- Article
29
Institute of Medicine report calls for extensive overhaul of drug safety procedures at FDA, CDER.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 607
- By:
- Publication type:
- Article
30
PBMs lukewarm to cost-cutting benefits of dose consolidation.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 603
- By:
- Publication type:
- Article
31
Generic medication discounts from retailers seek to limit patients' out-of-pocket cost-sharing.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 600
- By:
- Publication type:
- Article
32
Drug and Formulary Trends.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 596
- Publication type:
- Article
33
Transdermal rotigotine reduces motor symptoms in early Parkinson disease.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 592
- Publication type:
- Article
34
Statin therapy reduces severity of second ischemic stroke in patients with no history of coronary heart disease.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 592
- Publication type:
- Article
35
Studies of famotidine demonstrate improvement in cardiac symptoms of chronic heart failure.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 585
- Publication type:
- Article
36
Inhaled corticosteroids administered within 90 days of discharge reduce mortality rate in COPD patients.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 585
- Publication type:
- Article
37
Celecoxib demonstrates benefit in preventing premalignant colorectal adenomas, but cardiovascular risk raises concerns.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 581
- Publication type:
- Article
38
Diabetes associations develop consensus algorithm for the management of hyperglycemia in type 2 diabetes.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 581
- Publication type:
- Article
39
Rosiglitazone reduces the incidence of new-onset diabetes.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 578
- Publication type:
- Article
40
Ramipril fails to reduce the incidence of new-onset diabetes or death.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 578
- Publication type:
- Article
41
Long-term use of hormone replacement therapy may be associated with increased risk of ovarian cancer.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 576
- Publication type:
- Article
42
Early, intensive statin therapy reduces risk of death and cardiac events in patients hospitalized for ACS.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 576
- Publication type:
- Article
43
Focus on 2006: A year of novel pharmacologic agents in review.
- Published in:
- 2006
- Publication type:
- Editorial
44
Rimonabant: A novel CB1 receptor antagonist for the treatment of obesity.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 561
- By:
- Publication type:
- Article
45
FDA advises about potential attenuation of anti-platelet effect of low-dose aspirin with concomitant use of ibuprofen.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 558
- Publication type:
- Article
46
New meta-analyses evaluate effect of COX-2 inhibitors on renal and CV events, including arrhythmia.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 558
- Publication type:
- Article
47
FDA actions in brief.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 557
- Publication type:
- Article
48
New indications.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 556
- Publication type:
- Article
49
First-time generic approvals.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 556
- Publication type:
- Article
50
New molecular entities.
- Published in:
- Formulary, 2006, v. 41, n. 11, p. 555
- Publication type:
- Article